Friday, December 3, 2021
ADVT 
Life

US revokes emergency use of malaria drugs vs. coronavirus

Darpan News Desk The Canadian Press, 15 Jun, 2020 10:51 PM
  • US revokes emergency use of malaria drugs vs. coronavirus

U.S. regulators on Monday revoked emergency authorization for malaria drugs promoted by President Donald Trump for treating COVID-19 amid growing evidence they don’t work and could cause serious side effects.

The Food and Drug Administration said the drugs hydroxychloroquine and chloroquine are unlikely to be effective in treating the coronavirus. Citing reports of heart complications, the FDA said the drugs' unproven benefits “do not outweigh the known and potential risks.”

The decades-old drugs, also prescribed for lupus and rheumatoid arthritis, can cause heart rhythm problems, severely low blood pressure and muscle or nerve damage.

The move means that shipments of the drugs obtained by the federal government will no longer be distributed to state and local health authorities for use against the coronavirus. The drugs are still available for alternate uses, so U.S. doctors could still prescribe them for COVID-19 — a practice known as off-label prescribing.

Dr. Steven Nissen, a Cleveland Clinic researcher who has been a frequent FDA adviser, agreed with the decision and said he would not have granted emergency access in the first place.

“There has never been any high-quality evidence suggesting that hyrdoxychloroquine is effective” for treating or preventing coronavirus infection, he said, but there is evidence of serious side effects.

On Thursday, a National Institutes of Health panel of experts revised its recommendations to specifically recommend against the drug’s use except in formal studies, and “that, I’m sure, had influence on the FDA,” Nissen said.

The actions by FDA and NIH send a clear signal to health professionals against prescribing the drugs for coronavirus.

Trump aggressively pushed the drug beginning in the first weeks of the outbreak and stunned medical professionals when he revealed he took the drug preemptively against infection.

No large, rigorous studies have found the drugs safe or effective for preventing or treating COVID-19. And a string of recent studies made clear they could do more harm than good.

The FDA granted emergency use of the drugs for coronavirus patients in late March at the same time the U.S. government accepted 30 million doses of hydroxychloroquine and chloroquine that had been donated by two foreign drug manufacturers. Millions of those doses were shipped to U.S. hospitals to treat patient who weren’t enrolled in clinical trials.

But the FDA previously warned doctors that it had seen reports of dangerous side effects and heart problems reported to poison control centres and other health systems.

The agency said Monday it revoked the authorization in consultation with the Biomedical Advanced Research and Development Authority, or BARDA, which had requested the emergency use.

BARDA's former director said in April that he was removed from his job because he resisted political pressure from Trump appointees to allow widespread use of the malaria drugs. Rick Bright said he worked with FDA senior staff to limit the drugs’ authorization to patients hospitalized with COVID-19 and under professional supervision.

Among other issues, Bright objected to the fact that some of the doses imported by the U.S. government were manufactured at facilities in India and Pakistan that had not been reviewed by the FDA.

The FDA says it sampled and tested the imported drugs to confirm they met the agency’s standards for safety and quality.

MORE Life ARTICLES

Givenchy appoints American Matthew Williams as new designer

Givenchy appoints American Matthew Williams as new designer

French fashion house Givenchy has named American designer Matthew Williams as its new creative director, its third in three years. The appointment is effective from Tuesday.

Givenchy appoints American Matthew Williams as new designer

'We've missed it': Long lines form outside shops in England

'We've missed it': Long lines form outside shops in England

Long lines stretched along streets across England as shops selling items considered as nonessential during the coronavirus pandemic, such as sneakers and toys, welcomed customers on Monday for the first time since the U.K. was put into lockdown in late March.

'We've missed it': Long lines form outside shops in England

Coronavirus death rate is higher for those with chronic ills

Coronavirus death rate is higher for those with chronic ills

Death rates are 12 times higher for coronavirus patients with chronic illnesses than for others who become infected, a new U.S. government report says.

Coronavirus death rate is higher for those with chronic ills

Thai restaurants on thin ice despite return of alcohol sales

Thai restaurants on thin ice despite return of alcohol sales

Thailand's battered restaurant sector had two reasons to celebrate Monday as the country further eased its coronavirus restrictions. Bangkok’s many eateries, which reopened in May after being shut down for more than a month, are allowed to serve alcoholic drinks again, and there is no longer a curfew constraining late-night dining.

Thai restaurants on thin ice despite return of alcohol sales

Lessons to Learn From Covid-19 & Other Calamities

Lessons to Learn From Covid-19 & Other Calamities

"Rich or poor, educated or uneducated, belonging to one nation or another, ultimately each of us is just a human being like everyone else." - Dalai Lama

Lessons to Learn From Covid-19 & Other Calamities

Tim Hortons At Punjabi Market

Tim Hortons At Punjabi Market

Today, their restaurant is an integral part of the Punjabi Market where conversations take form and connections are built. 

Tim Hortons At Punjabi Market

PrevNext